M

Mathias Falcenberg

Venture Partner
๐Ÿ’ผ Partner at V-Bio Ventures โ†’
About

Mathias Falcenberg joined V-Bio Ventures as Venture Partner in February 2025. His experience spans the healthcare industry from an entrepreneur, investor, and corporate perspective. At Merck KGaA, he and his team foster external innovation for new modalities and technologies like PROTACs (Amphista, Proxygen), AIDD (Exscientia, Benevolent AI, Caris) as well as NBE and ADC approaches (Mersana, Biolojics) by driving the search, evaluation, due diligence and workplan execution. Before joining Merck, Mathias worked at Forbion where he gained substantial insights into venture capital methods and processes across the sectors of therapeutics, diagnostics, and MedTech. Mathias is a trained biologist from the TU-Darmstadt and earned his PhD in the lab of Prof. Dr. Axel Ullrich at the Max-Planck-Institute where he co-founded and scientifically headed an early drug discovery biotech start-up.

Focus Areas

Therapeutics, Diagnostics, MedTech

Location

๐Ÿ“ Based in Flanders

Verified Contact & Outreach Agent

Direct Professional Email Pattern

[email protected] | [email protected]

AI Outreach Agent Pitch Writer

Compose an personalized, high-converting outreach message targeting their exact investment interest...

Unlock Direct Partner Outreach

View verified contact information and use our active Outreach Composer agent to draft custom intro pitches in seconds.

Connect via GRID to Outreach

100% free account ยท Get started in 1-click